Gil M. Labrucherie, SVP & Chief Financial Officer at NEKTAR THERAPEUTICS (NKTR), sold 7,534 shares at $31.37 ($236K) on 2019-05-16, disclosed to the SEC on 2019-05-17.
Seasonal sale ($236k) by SVP & Chief Financial Officer — this insider has traded NKTR in May in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.37 | 3,767 | $118K | 50.0% |
| 2 | $31.37 | 3,767 | $118K | 50.0% |
| Total | $31.37 avg | 7,534 | $236K | 100% |
| Filing → |
| NKTR | SELL | 2022-05-17 | $138K | — | Filing → |
| RZLT | BUY | 2022-05-09 | $400K | — | Filing → |
| NKTR | SELL | 2022-02-18 | $166K | — | Filing → |